Proclara Biosciences
Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggregation technology.
General Information
BounceWatch is an independent company data service, not affiliated with Proclara Biosciences. To contact Proclara Biosciences, visit proclarabio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Proclara Biosciences compare?
A PDF of Proclara Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Proclara Biosciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Proclara Biosciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Proclara Biosciences
Business keywords: neurodegenerative diseases, protein disaggregation, drug development, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, therapeutics, preclinical research, neuropharmacology, innovation, biopharmaceuticals, Cambridge, Massachusetts
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $6.92M | - |
|
09 Nov 2018 |
| Series E | $47.00M | - |
|
07 Sep 2016 |
| Series D | $10.00M | - |
|
14 Jan 2015 |
| Series D | $17.00M | 2 |
|
25 Mar 2014 |
| Series C | $6.40M | 2 |
|
06 May 2013 |
| Series B | $9.00M | 2 |
|
08 Mar 2012 |
| Series B | $12.40M | 2 |
|
01 Mar 2011 |
| Series A | $7.00M | - |
|
10 Mar 2008 |
Proclara Biosciences Alternatives & Competitors
View All Alternatives-logo.jpg "Kineta (Reverse Merger With Yumanity Therapeutics)"){kind=logo}
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfolding.
Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s...
Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.
FAQ About Proclara Biosciences
Source: BounceWatch company record for Proclara Biosciences, https://bouncewatch.com/company/proclara-biosciences, updated 26 December 2024. When citing, please name BounceWatch and link this page.
